$RLFTF With all that's going on more shares, Compa
Post# of 653
(Total Views: 374)
Posted On: 12/21/2020 8:01:18 AM
$RLFTF With all that's going on more shares, Companies.. Heavy hitters joining.. etc.. I'm starting to think they're setting up this little company to Be, Act, Handle and Produce Like a Big Pharma.
Look at pg 4: “Validation from NIH, BARDA, and other stakeholders"”
https://www.sec.gov/Archives/edgar/data/17194..._ex992.htm - DD by vader69
DD by JB (copy) Some thoughts on the SEC Filing:
https://www.sec.gov/Archives/edgar/data/17194..._ex992.htm
The NRX SPAC merger document has provided our most recent up to date look at Relief’s data to date, specifically with the trial and future events. This SEC document was just filed yesterday. It notes that we now have: 200 enrolled in the clinical trial and 235
enrolled in the EAP trial.
This is a big gain from the 12/7/20 PR where they announced the 165 milestone in the clinical trial and 200 in the EAP.
More importantly, the SEC document mentions on page 4 “Validation from NIH, BARDA, and other stakeholders"
Lastly, on pg 18 of the report, “Inclusion in NIH TESICO/ACTIV3b trial” and an I-spy clinical trial contract for quantum healthcare.
ACTIV stands for Accelerating COVID-19 Therapeutic Interventions and Vaccines.
Heres the US NIH's ACTIV website:
https://www.nih.gov/research-training/medical...v#overview
Here is info about the I-Spy trial
https://www.quantumleaphealth.org/portfolio/i-spy-covid
BARDA as a possible stake holder on page 4 is a big deal. The RLF EGM PR specifically said "not directly" for a reason. I feel like we’re finally getting more proof of all the great things RLF & NeuroRx have been doing these past few months while we held. I suspect when we finally get EUA, there’s going to be a flood of news regarding Data,OWS, BARDA, manufacturing with Bachum, Nephron -and delivery with our unknown delivery contractor
Bottom line is that "ITS A BIG FKN DEAL"...
Best,
-JB
Look at pg 4: “Validation from NIH, BARDA, and other stakeholders"”
https://www.sec.gov/Archives/edgar/data/17194..._ex992.htm - DD by vader69
DD by JB (copy) Some thoughts on the SEC Filing:
https://www.sec.gov/Archives/edgar/data/17194..._ex992.htm
The NRX SPAC merger document has provided our most recent up to date look at Relief’s data to date, specifically with the trial and future events. This SEC document was just filed yesterday. It notes that we now have: 200 enrolled in the clinical trial and 235
enrolled in the EAP trial.
This is a big gain from the 12/7/20 PR where they announced the 165 milestone in the clinical trial and 200 in the EAP.
More importantly, the SEC document mentions on page 4 “Validation from NIH, BARDA, and other stakeholders"
Lastly, on pg 18 of the report, “Inclusion in NIH TESICO/ACTIV3b trial” and an I-spy clinical trial contract for quantum healthcare.
ACTIV stands for Accelerating COVID-19 Therapeutic Interventions and Vaccines.
Heres the US NIH's ACTIV website:
https://www.nih.gov/research-training/medical...v#overview
Here is info about the I-Spy trial
https://www.quantumleaphealth.org/portfolio/i-spy-covid
BARDA as a possible stake holder on page 4 is a big deal. The RLF EGM PR specifically said "not directly" for a reason. I feel like we’re finally getting more proof of all the great things RLF & NeuroRx have been doing these past few months while we held. I suspect when we finally get EUA, there’s going to be a flood of news regarding Data,OWS, BARDA, manufacturing with Bachum, Nephron -and delivery with our unknown delivery contractor
Bottom line is that "ITS A BIG FKN DEAL"...
Best,
-JB
(0)
(0)Mondobiotech Holding AG Basel (RLFTF) Stock Research Links
$MJ